Novelion
Vancouver
British Columbia
Canada
About Novelion
CEO: Mary Szela33 articles about Novelion
-
Novelion Provides Update on Interim Distribution to Registered Shareholders
1/26/2021
Novelion Therapeutics Inc. (“ Novelion ” or the “ Company ”) by Alvarez & Marsal Canada Inc., Novelion’s court appointed liquidator (the “ Liquidator ”) today announces that the timing of the previously announced interim distribution to its registered shareholders (the “ Interim Distribution ”) has been delayed.
-
Novelion Therapeutics Provides Updates on Voluntary Liquidation and Other Matters
11/21/2019
At the Company’s 2019 Annual General Meeting held November 5, 2019, shareholders voted in favor of all proposals contained in the Company’s proxy statement dated October 3, 2019
-
Novelion Therapeutics Announces Sentencing of Subsidiary Aegerion Pharmaceuticals
1/31/2018
Financial terms of the sentence align with previous company filings.
-
Novelion will slash an unknown number of jobs as it initiates "significant cost reduction plans."
-
Novelion Therapeutics Appoints Michael Price as Senior Vice President and Chief Financial Officer
12/4/2017
Gregory Perry has resigned as CFO of Novelion to pursue other opportunities, and will remain with the Company until December 31, 2017 to enable an effective transition.
-
Novelion Therapeutics Provides Update on Agreement Between Aegerion Pharmaceuticals and U.S. Department of Justice
11/21/2017
The Company, in consultation with its outside counsel, is currently evaluating its options and next steps.
-
Novelion Therapeutics Reports Third Quarter 2017 Financial Results and Announces Leadership Change
11/9/2017
The company has commenced a search for a new CEO to lead the Company in the next stage of growth.
-
Novelion Therapeutics Expands Leadership Team With Appointment of Jeffrey Hackman as Chief Operating Officer
10/31/2017
Jeffrey Hackman was most recently senior vice president, head of the US Internal Medicine and Oncology franchises for Shire.
-
Novelion Strengthens Leadership Team With Appointment Of Murray Stewart, M.D., As Executive Vice President, Head Of R&D
10/12/2017
-
Novelion Observes Familial Hypercholesterolemia Awareness Day
9/25/2017
-
Novelion Release: Metreleptin And Lipodystrophy Data Presented At The International Meeting Of Pediatric Endocrinology
9/15/2017
-
Novelion Appoints Suzanne Bruhn, Ph.D. To Board Of Directors
9/11/2017
-
Novelion Reports Second Quarter 2017 Financial Results
8/8/2017
-
Novelion Appoints Mark DiPaolo To Board Of Directors
8/2/2017
-
Novelion To Announce Second Quarter 2017 Financial Results On August 8, 2017
7/28/2017
-
Novelion Added To The Russell 3000 & Russell Microcap Indexes
6/26/2017
-
Novelion Announces Presentation Of Metreleptin Data At American Diabetes Association
6/12/2017
-
Novelion Appoints John J. Orloff, M.D., To Its Board Of Directors, Steps Down As EVP, Head Of R&D
6/2/2017
-
Novelion CEO Steps Down From Novo Nordisk A/S Board Due To NASH Conflict
5/17/2017
-
Novelion Reports First Quarter 2017 Financial Results
5/9/2017